Nigeria Pharmaceuticals & Healthcare Report Q2 2018

Nigeria Pharmaceuticals & Healthcare Report Q2 2018

BMI View:

Nigeria's pharmaceutical and healthcare industry is a high-risk investment prospect in the Sub-Saharan African region,yet the opportunities for potential medicine sales are still vastly unexplored. The majority of multinational players will continue to optfor an indirect presence as the business climate remains decidedly difficult, yet the long-term opportunities will manifest in line witheconomic growth and greater investor sentiment. While opportunities for drugmakers will continue to be stimulated by the size andwealth of the market, the proposed healthcare budget for 2018 is indicative of the lasting effects from the oil price collapse and willensure a challenging near-term environment for healthcare providers and multinational drugmakers in Nigeria.

BMI Industry View
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Sub-Saharan Africa Pharmaceuticals: A Highly Challenging Region For Innovative Drugmakers
Nigeria Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Market Overview
Competitive Landscape
Company Profile
Fidson Healthcare
May & Baker Nigeria
Merck & Co
Neimeth International Pharmaceuticals
Demographic Forecast
Demographic Outlook
Pharmaceuticals & Healthcare Glossary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook